Ferrara, Felicetto <br/><br/>
Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.  [electronic resource] 

 -  American journal of hematology  Sep 2010 
 - 687-90 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1096-8652 
<br/><br/><label>Standard No.: </label>10.1002/ajh.21791  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Blast Crisis--genetics<br/>Bone Marrow--pathology<br/>Chromosome Aberrations<br/>Cytarabine--administration & dosage<br/>Disease-Free Survival<br/>Etoposide--administration & dosage<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Idarubicin--administration & dosage<br/>Leukemia, Myeloid, Acute--genetics<br/>Male<br/>Middle Aged<br/>Mutation<br/>Remission Induction<br/>Retrospective Studies<br/>Survival Rate<br/>Time Factors<br/>Transplantation, Homologous<br/>Vidarabine--administration & dosage<br/>Young Adult